Published in
BMJ Publishing Group, Evidence Based Medicine, 1(16), p. 20-21
DOI: 10.1136/ebm1165
Links
Tools
Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - the two highest quality studies identified do find prostate cancer-related mortality reductions
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 